Skip to content
LexBuild

Notice of Availability for Exclusive, Non-Exclusive, or Partially-Exclusive Licensing of an Invention Concerning a Method and Device for Detection of Bioavailable Drug Concentration in a Fluid Sample 

---
identifier: "/us/fr/2012-18"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Notice of Availability for Exclusive, Non-Exclusive, or Partially-Exclusive Licensing of an Invention Concerning a Method and Device for Detection of Bioavailable Drug Concentration in a Fluid Sample"
title_number: 0
title_name: "Federal Register"
section_number: "2012-18"
section_name: "Notice of Availability for Exclusive, Non-Exclusive, or Partially-Exclusive Licensing of an Invention Concerning a Method and Device for Detection of Bioavailable Drug Concentration in a Fluid Sample"
positive_law: false
currency: "2012-01-06"
last_updated: "2012-01-06"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Defense Department"
document_number: "2012-18"
document_type: "notice"
publication_date: "2012-01-06"
agencies:
  - "Defense Department"
  - "Army Department"
fr_citation: "77 FR 783"
fr_volume: 77
fr_action: "Notice."
---

#  Notice of Availability for Exclusive, Non-Exclusive, or Partially-Exclusive Licensing of an Invention Concerning a Method and Device for Detection of Bioavailable Drug Concentration in a Fluid Sample

**AGENCY:**

Department of the Army, DoD.

**ACTION:**

Notice.

**SUMMARY:**

The invention provides a method for the controlled delivery of a drug as a function of bioavailable drug concentration, a sensor device for detecting bioavailable drug concentration, and a delivery device that controls delivery of the drug based on the real-time detection of bioavailable drug concentration. Announcement is made of the availability for licensing of the invention set forth in International Patent Application No. PCT/US2009/060852 entitled, “Method and Device for Detection of Bioavailable Drug Concentration in a Fluid Sample,” filed on October 15, 2009 (which claims the benefit of U.S. Provisional Patent Application Serial No. 651/105,604 filed October 15, 2008). The United States Government, as represented by the Secretary of the Army, has rights to this invention. U.S. and selected foreign rights are available.

**ADDRESSES:**

Commander, U.S. Army Medical Research and Materiel Command, ATTN: Command Judge Advocate, MCMR-JA, 504 Scott Street, Fort Detrick, Frederick, MD 21702-5012.

**FOR FURTHER INFORMATION CONTACT:**

For patent issues, Ms. Elizabeth Arwine, Patent Attorney, (301) 619-7808. For licensing issues, Dr. Paul Mele, Office of Research and Technology Applications (ORTA), (301) 619-6664, both at telefax (301) 619-5034.

**SUPPLEMENTARY INFORMATION:**

The invention relates to the method of electrochemical detection of bioavailable drug concentration intended to be used to modify the  delivery rate of the drug to a patient during real-time.

Brenda S. Bowen,

Army Federal Register Liaison Officer.